APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

BACKGROUND: The APOE genotype predicts the age at onset of Alzheimer disease (AD) and neuropathologic progression. However, studies relating APOE alleles to the rate of cognitive decline have been inconclusive. This may stem from their use of linear statistical analyses. OBJECTIVE: To model relation...

Detaylı Bibliyografya
Asıl Yazarlar:	Martins, C, Oulhaj, A, de Jager, C, Williams, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2005

Benzer Materyaller

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele
Yazar:: Marian Shahid, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease
Yazar:: Haixu Ma, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.
Yazar:: Laura B Zahodne, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
Yazar:: B.V.P. de-Almada, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
Yazar:: Kazushi Suzuki, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
Yazar:: B.V.P. de-Almada, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
Yazar:: Oulhaj, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
Yazar:: Holmes, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
Yazar:: Jori Tomassen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease
Yazar:: Coralie Barbe, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Periodontitis and Cognitive Decline in Alzheimer's Disease.
Yazar:: Mark Ide, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease
Yazar:: Céline H. De Jager, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
Yazar:: Allen, G, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
Yazar:: I. K. Malashenkova, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
Yazar:: Pia Kivisäkk, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Yazar:: Hákon Valur Dansson, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
Yazar:: Lai, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
Yazar:: Nicholas C. Cullen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

APOE epsilon 4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
Yazar:: Lai, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
Yazar:: Lai, M, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
Yazar:: Selma M. Soyal, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment
Yazar:: Mana Shams, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease
Yazar:: Sungyang Jo, ve diğerleri
Baskı/Yayın Bilgisi: (2021-04-01)

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
Yazar:: Yury Loika, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Rates of decline in Alzheimer disease decrease with age.
Yazar:: Dominic Holland, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Predicting cognitive decline in healthy older adults.
Yazar:: De Jager, C, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
Yazar:: Belbin, O, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample
Yazar:: Xiaoran Liu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Effect of APOE and CD33 on Cognitive Decline.
Yazar:: Kathleen M Hayden, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Yazar:: Heather E. Dark, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
Yazar:: Joseph Giorgio, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Selective effects of the APOE ε4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease
Yazar:: Mitchell K.P. Lai, ve diğerleri
Baskı/Yayın Bilgisi: (2006-06-01)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
Yazar:: Taizen Nakase, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
Yazar:: Jagan A. Pillai, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
Yazar:: Corinna M. Bauer, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer’s Disease
Yazar:: Florian U. Fischer, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
Yazar:: Jagan A. Pillai, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Correction: Effect of APOE and CD33 on Cognitive Decline.
Yazar:: Kathleen M Hayden, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)